• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Characterization of cancer development risk following pediatric radiation exposure from computed tomography

byRhianna DavisandAlex Chan
May 29, 2023
in Emergency, Hematology, Imaging and Intervention, Oncology, Pediatrics
Reading Time: 3 mins read
Imatinib safe and effective as long-term treatment for chronic myeloid leukemia: The IRIS trial
Share on FacebookShare on Twitter

Evidence rating level: 3 (Average)

1. Exposure to a higher cumulative number of pediatric CT scans is associated with a greater risk of developing intracranial tumours, leukemia, and non-Hodgkin lymphoma. 

2. Participants with 4 or more CT scans at or before age 6 had the greatest risk of developing cancer. 
Study Rundown: Low-dose radiation is known to be oncogenic, and exposure to diagnostic CT is associated with greater cancer risk in both adults and children. Previous studies have not addressed whether the risk of developing cancer is influenced by the age of CT exposures or the cumulative number of CT scans. This population-based, nested case-control study aimed to determine whether radiation exposure from CT at or before age 18 increases the risk of developing intracranial tumours, leukemia, or lymphoma. It was determined that exposure to one pediatric CT scan did not increase cancer risk, but participants with 2-3 pediatric CT scans were at increased risk of developing intracranial tumours. Participants with 4 or more pediatric CT scans were at an increased risk of developing intracranial tumours, leukemia, and non-Hodgkin lymphoma. Furthermore, participants with 4 or more CT scans at or before the age of 6 were at the greatest risk of developing cancer. Overall, this study found a positive relationship between the cumulative number of pediatric CT scans and the development of intracranial tumours, leukemia, and non-Hodgkin lymphoma, as well as a positive association between younger age at the time of CT exposure and malignancy risk. Study findings highlight the importance of the judicious use of CT scans in the pediatric population, recognizing that the benefits of diagnostic imaging must be weighed against the risks of oncogenic radiation exposure.

Click here to read the study in CMAJ
Study Rundown In-Depth [nested case control]: Data was collected from the National Health Insurance Research Database (NHIRD) in Taiwan. The control population included all NHRID beneficiaries under the age of 25 between January 1, 2000, and December 31, 2013. The case population included those with intracranial tumours, leukemia, or lymphomas diagnosed during this study period. Patients with known cancer-predisposing conditions or malignancies diagnosed prior to the study period were excluded from this analysis. Controls (n = 78,057) were matched to cases (n = 7807) at a 10:1 ratio, based on sex, date of birth, and cohort entry date. Exposure to one pediatric CT scan did not increase cancer risk. Participants with 2-3 pediatric CT scans had an increased risk of developing intracranial tumours (adjusted OR 2.36, 95% CI 1.40-3.97), but no increased risk of leukemia or lymphoma. Participants with 4 or more pediatric CT scans were at increased risk of developing intracranial tumours (adjusted OR 9.01, 95% CI 2.89-28.11), leukemia (adjusted OR 4.80, 95% CI 1.79-12.84), non-Hodgkin lymphoma (adjusted OR 6.76, 95% CI 1.91-23.96), but not Hodgkin lymphoma (adjusted OR 3.61, 95% CI 0.37-35.08).  The age of CT exposure was also found to impact cancer risk. Participants exposed to 4 or more CT scans at or before the age of 6 had the highest cancer risk, (adjusted OR 22.95, 95% CI 5.93-88.81), followed by ages 7-12 (adjusted OR 5.69, 95% CI 1.67-19.46), and then ages 13-18 (adjusted OR 3.20, 95% CI 1.27-8.06). p < 0.001 for this trend. Overall, this study emphasizes the importance of considering the risks associated with diagnostic imaging involving radiation, especially when caring for pediatric populations.

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

2 Minute Medicine Rewind September 7, 2026

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Tags: hematologyleukemiaoncologyradiationradiology
Previous Post

Yoga supports the wellbeing of individuals with mild cognitive impairment or dementia

Next Post

Intravascular imaging-guided PCI has a lower mortality rate than angiography-guided PCI

RelatedReports

Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening
Chronic Disease

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

September 7, 2026
Long-term outcomes for off-pump and on-pump CABG are similar
Weekly Rewinds

2 Minute Medicine Rewind September 7, 2026

September 7, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026
Next Post
PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study

Intravascular imaging-guided PCI has a lower mortality rate than angiography-guided PCI

Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men

HIV status does not impact mpox treatment with tecovirimat

Patient Basics: Chronic Hepatitis

Amoxicillin-clavulanate not associated with improved survival outcomes in patients with severe alcohol-related hepatitis receiving prednisolone

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.